MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder marked by hallmark pathologies such as amyloid-beta (Aβ) plaques, tau neurofibrillary tangles, neuroinflammation, and widespread neuronal loss [1].